reports
Ring Energy Announces Departure of Chief Financial Officer and Transit...
Ring Energy Announces Departure of Chief Financial Officer and Transition Plan THE WOODLANDS, Texas, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced that its Chief Financial Officer, Travis T. Thomas, has resigned effective immediately to pursue other opportunities. Mr. Thomas’ resignation was not a result of any disagreement between the Company and Mr. Thomas on any financial or other matter related to the operations, policies, or practices of the Company. Rocky Kwon, the Company’s Vice President of Accounting, Controll...
Clearside Biomedical Announces Multiple Presentations on Suprachoroida...
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress - Presentations Highlight the Versatility of Clearside’s SCS Microinjector® Platform for the Treatment of Multiple Retinal Diseases - - CLS-AX Trial Designs in Wet AMD and Diabetic Retinopathy to be Featured in Presentation by Dr. Sobha Sivaprasad - ALPHARETTA, Ga., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the...
Ring Energy Announces Third Quarter 2025 Debt Reduction Target and Pro...
Ring Energy Announces Third Quarter 2025 Debt Reduction Target and Provides Stock Ownership Update THE WOODLANDS, Texas, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today reported its debt reduction target for the third quarter of 2025 and the change in ownership status of a previous large stockholder. Ring Energy has established a debt reduction target of approximately $18 million for the third quarter of 2025. The Company anticipates it will have approximately $430 million in borrowings outstanding on its credit facility as of Se...
Ring Energy Announces Second Quarter 2025 Results and Updates Guidance
Ring Energy Announces Second Quarter 2025 Results and Updates Guidance THE WOODLANDS, Texas, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today reported operational and financial results for the second quarter of 2025 and updated guidance for the remainder of the year. Second Quarter 2025 Highlights Sold record 14,511 barrels of oil per day (“Bo/d”), exceeding the mid point of guidance and record 21,295 barrels of oil equivalent per day (“Boe/d”) which was near the mid point of guidance;Reported net income of $20.6 million, or $0...
Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Trea...
Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada - XIPERE Now Approved for Use in Multiple Global Markets - - Continued Global Expansion and Validation of Clearside’s Suprachoroidal Space Injection Platform Featuring its Commercially Proven SCS Microinjector® - ALPHARETTA, Ga., July 23, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that Health Canada has...
Clearside Biomedical Announces Plan to Explore Strategic Alternatives ...
Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline - Proven In-Office, Repeatable, Non-Surgical Procedure for the Targeted Delivery of a Wide Variety of Therapies for Serious Retinal Diseases - - CLS-AX Phase 3-Ready Asset with Global Investigator Support and FDA Alignment on Pivotal Trial Program in wet AMD - - Validated Delivery Platform with Five Commercial and Late-Stage Development Suprachoroidal Licensing Collaborations - ALPHARETTA, G...
Ring Energy Announces Timing of Second Quarter 2025 Earnings Release a...
Ring Energy Announces Timing of Second Quarter 2025 Earnings Release and Conference Call THE WOODLANDS, Texas, July 16, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced the timing of its second quarter 2025 earnings release and conference call. Ring plans to issue its second quarter 2025 earnings release after the close of trading on Wednesday, August 6, 2025. The Company has scheduled a conference call on Thursday, August 7, 2025 at 11:00 a.m. ET (10:00 a.m. CT) to discuss its second quarter operational and financial results. To p...
Ring Energy to Participate in Water Tower Research Fireside Chat on Ju...
Ring Energy to Participate in Water Tower Research Fireside Chat on July 15, 2025 THE WOODLANDS, Texas, July 14, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced its participation in a fireside chat with Water Tower Research (“WTR”) on Tuesday, July 15, 2025 at 10:00 AM Central Time. As part of WTR’s ongoing Fireside Chat Series, Jeff Robertson, Managing Director at WTR, will lead an in-depth conversation with Paul McKinney, Ring’s Chairman and Chief Executive Officer. Included in the discussion will be a variety of important top...
Ring Energy Announces Credit Facility Extension and Amendment
Ring Energy Announces Credit Facility Extension and Amendment THE WOODLANDS, Texas, June 18, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced that the borrowing base was affirmed at $585 million under its $1.0 billion senior secured credit facility (the “Credit Facility”). In addition, the Credit Facility term was extended to June 2029, and Bank of America, N.A. was named as new Administrative Agent. KEY HIGHLIGHTS Entered into a Third Amended and Restated Credit Agreement with a borrowing base of $585 million;Extended Credit Fac...
Clearside Biomedical Announces Multiple Presentations to be Featured a...
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting - Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications - - CLS-AX Combines the Flexibility of Anti-VEGF Therapies with the Long-Lasting Benefits of a Tyrosine Kinase Inhibitor - ALPHARETTA, Ga., June 17, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), a...
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2...
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum ALPHARETTA, Ga., May 21, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that management will participate in a fireside chat at the Stifel 2025 Virtual Ophthalmology Forum on Tuesday, May 27, 2025, at 9:00 a.m. ET. A link to the live and archived webcast may be accessed on the Clearside website under the Investors sectio...
Clearside Biomedical Announces First Quarter 2025 Financial Results an...
Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update - Successful End-of-Phase 2 Meeting with FDA Led to Alignment on Phase 3 Program Design for CLS-AX in Wet AMD - - CLS-AX Targets Commercially Attractive Product Profile with Three-to-Six Month Flexible Maintenance Dosing - - Multiple Milestones Achieved by Commercial and Development Partners - - Use of Suprachoroidal Drug Delivery Featured in Over 15 Presentations at Major Ophthalmic Medical Meetings This Year - ALPHARETTA, Ga., May 14, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CLSD), a biophar...
Clearside Biomedical Data Featured in Six Presentations at Association...
Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting Strong Clinical Evidence Supports Use of the Suprachoroidal Platform in Expanding the Standard of Care for the Treatment of Multiple Macular Diseases ALPHARETTA, Ga., May 09, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that six presentations related to the...
Clearside Biomedical to Report First Quarter 2025 Financial Results on...
Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 ALPHARETTA, Ga., May 08, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that its first quarter 2025 financial results will be reported on Wednesday, May 14, 2025 after the close of the financial markets. The Company will not be hosting a conference call this quarter. Information about the Com...
Ring Energy Announces First Quarter 2025 Results and Provides Updated ...
Ring Energy Announces First Quarter 2025 Results and Provides Updated 2025 Outlook THE WOODLANDS, Texas, May 07, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today reported operational and financial results for first quarter 2025 and provided updated guidance for the second half of the year. First Quarter 2025 Highlights Sold 12,074 barrels of oil per day (“Bo/d”) (> high end of guidance) and 18,392 barrels of oil equivalent per day (“Boe/d”) (> mid point of guidance);Reported net income of $9.1 million, or $0.05 per diluted share...
Clearside Biomedical to Participate in a Fireside Chat at the Citizens...
Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference ALPHARETTA, Ga., May 01, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that management will participate in a fireside chat at the Citizens Life Sciences Conference on Wednesday, May 7, 2025, at 1:00 p.m. ET. A link to the live and archived webcast may be accessed on the Clearside website under the Investors section: . An a...
Ring Energy Updates Second Quarter 2025 Guidance
Ring Energy Updates Second Quarter 2025 Guidance ~ Reaffirms Sales Volume Guidance and Substantially Reduces Capital Guidance ~ THE WOODLANDS, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today provided updated guidance for the second quarter of 2025, which included reaffirming its previous outlook for oil and total sales volumes despite a significant reduction in the Company’s capital spending guidance, which was lowered in response to the recent decline in oil prices. KEY Q2 UPDATED GUIDANCE HIGHLIGHTS Reduce...
Ring Energy Provides Operational Update - Amended to Correct Wells Dri...
Ring Energy Provides Operational Update - Amended to Correct Wells Drilled in First Quarter 2025 ~ Announces Timing of First Quarter Earnings Conference Call ~ THE WOODLANDS, Texas, April 18, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today provided an operational update, including first quarter 2025 oil sales volumes above the high end of the Company’s guidance range and total sales volumes above the midpoint of guidance. The Company also announced the timing of Ring’s quarterly results conference call. KEY HIGHLIGHTS Produced over 12,000...
Ring Energy Provides Operational Update
Ring Energy Provides Operational Update ~ Announces Timing of First Quarter Earnings Conference Call ~ THE WOODLANDS, Texas, April 17, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today provided an operational update, including first quarter 2025 oil sales volumes above the high end of the Company’s guidance range and total sales volumes above the midpoint of guidance. The Company also announced the timing of Ring’s quarterly results conference call. KEY HIGHLIGHTS Produced over 12,000 barrels of oil per day (“Bo/d”), exceeding h...
Ring Energy Provides Board of Directors Update
Ring Energy Provides Board of Directors Update THE WOODLANDS, Texas, April 11, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today provided an update concerning its Board of Directors (the “Board”), including the retirement of Ms. Regina Roesener effective April 14, 2025 and the appointment of Ms. Carla Tharp to the Board effective April 14, 2025 who will serve as an independent Director. Mr. Paul D. McKinney, Chairman of the Board and Chief Executive Officer, commented, “It has been a pleasure to work closely with Regina as a fellow Director...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.